JPH05506850A - 好中球刺激ペプチド - Google Patents
好中球刺激ペプチドInfo
- Publication number
- JPH05506850A JPH05506850A JP91505600A JP50560091A JPH05506850A JP H05506850 A JPH05506850 A JP H05506850A JP 91505600 A JP91505600 A JP 91505600A JP 50560091 A JP50560091 A JP 50560091A JP H05506850 A JPH05506850 A JP H05506850A
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- amino acid
- neutrophil
- acid sequence
- substantially corresponds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (11)
- (1)図1の54番目のアミノ酸から94番目のアミノ酸までに実質上対応する アミノ酸配列を有し、もしくは、その一部を有し、N−フォルミル−L−メチオ ニル−L−ロイシル−L−フェニルアラニン〔N−formy1−L−meth ionyl−L−leucyl−L−phenylalanine]と共に処理 されることで、好中球の超酸化物生産及びレスビラトリーバースト〔respi ratoryburst]を高めるための準備をする能力を有するペプチド。
- (2)請求項1記載のペプチドにおいて、図1の54番目のアミノ酸から94番 目のアミノ酸までに実質上対応するアミノ酸配列を有するペプチド。
- (3)請求項1記載のペプチドにおいて、図1の54番目のアミノ酸から68番 目のアミノ酸までに実質上対応するアミノ酸配列を有するペプチド。
- (4)請求項1記載のペプチドにおいて、図1の73番目のアミノ酸から94番 目のアミノ酸までに実質上対応するアミノ酸配列を有するペプチド。
- (5)請求項1記載のペプチドにおいて、図1の70番目のアミノ酸から80番 目のアミノ酸までに実質上対応するアミノ酸配列を有するペプチド。
- (6)請求項1ないし5のいずれかに記載のペプチドの3次光構造に実質上対応 する3次元構造を有し、N−フォルミル−L−メチオニル−L−ロイシル−L− フェニルアラニン[N−formy1−L−methionyl−L−leuc yl−L−phenylalanine]と共に処理されることで、好中球の超 酸化物生産及びレスビラトリーバースト〔respiratoryburst] を高めるため準備をする能力を有する化合物。
- (7)好中球の機能低下を有する患者の治療方法であって、請求項1ないし5の いずれかに記載のペプチドの効果的治療量を前記患者に投与することからなる方 法。
- (8)請求項7記載の方法において、前記患者が後天性免疫不全症候群に罹って いる方法。
- (9)請求項7記載の方法において、前記患者が癌に罹っている方法。
- (10)請求項3記載のペプチドの効果的治療量を炎症性症候群に罹っている患 者に投与することからなる方法。
- (11)請求項10記載の方法において、前記炎症性症候群がリューマチ性関節 炎もしくは成人呼吸窮迫症候群である方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPJ906590 | 1990-03-12 | ||
AU9065 | 1999-03-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05506850A true JPH05506850A (ja) | 1993-10-07 |
JP3241041B2 JP3241041B2 (ja) | 2001-12-25 |
Family
ID=3774545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50560091A Expired - Fee Related JP3241041B2 (ja) | 1990-03-12 | 1991-03-12 | 好中球刺激ペプチド |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0519976B1 (ja) |
JP (1) | JP3241041B2 (ja) |
AU (1) | AU642487B2 (ja) |
CA (1) | CA2078000C (ja) |
DE (1) | DE69124795T2 (ja) |
DK (1) | DK0519976T3 (ja) |
SG (1) | SG46398A1 (ja) |
WO (1) | WO1991013908A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6375928B1 (en) * | 1990-03-12 | 2002-04-23 | Peptech Limited | Neutrophil stimulating peptides |
US5587457A (en) * | 1990-03-12 | 1996-12-24 | Peptide Technology Limited | Neutrophil stimulating peptides |
WO1991014702A1 (en) * | 1990-03-19 | 1991-10-03 | Peptide Technology Ltd. | Anti-tumour peptides |
WO1997048725A1 (en) * | 1996-06-21 | 1997-12-24 | Peptech Limited | Novel peptides for prevention and treatment of infection |
US7851486B2 (en) | 2002-10-17 | 2010-12-14 | Decode Genetics Ehf. | Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR851626B (ja) * | 1984-07-05 | 1985-11-26 | Genentech Inc | |
DE10399036I1 (de) * | 1989-08-07 | 2004-04-01 | Peptide Technology Ltd | Bindeligande für Tumornekrosisfaktor. |
WO1991014702A1 (en) * | 1990-03-19 | 1991-10-03 | Peptide Technology Ltd. | Anti-tumour peptides |
WO1991017180A1 (en) * | 1990-04-27 | 1991-11-14 | Peptide Technology Ltd | Peptides derived from human tumour necrosis factor alpha and useful against intracellular malarial parasites |
-
1991
- 1991-03-12 SG SG1996004253A patent/SG46398A1/en unknown
- 1991-03-12 DK DK91905955.0T patent/DK0519976T3/da active
- 1991-03-12 CA CA002078000A patent/CA2078000C/en not_active Expired - Lifetime
- 1991-03-12 EP EP91905955A patent/EP0519976B1/en not_active Expired - Lifetime
- 1991-03-12 JP JP50560091A patent/JP3241041B2/ja not_active Expired - Fee Related
- 1991-03-12 DE DE69124795T patent/DE69124795T2/de not_active Expired - Fee Related
- 1991-03-12 WO PCT/AU1991/000086 patent/WO1991013908A1/en active IP Right Grant
- 1991-03-12 AU AU74762/91A patent/AU642487B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0519976B1 (en) | 1997-02-26 |
DE69124795T2 (de) | 1997-06-26 |
CA2078000C (en) | 2001-10-02 |
JP3241041B2 (ja) | 2001-12-25 |
AU7476291A (en) | 1991-10-10 |
CA2078000A1 (en) | 1991-09-13 |
DK0519976T3 (da) | 1997-04-01 |
EP0519976A1 (en) | 1992-12-30 |
DE69124795D1 (de) | 1997-04-03 |
SG46398A1 (en) | 1998-02-20 |
WO1991013908A1 (en) | 1991-09-19 |
AU642487B2 (en) | 1993-10-21 |
EP0519976A4 (en) | 1993-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pennica et al. | Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin | |
JPH08511167A (ja) | ケモカインの生物学的活性の強化法 | |
CA2112907C (en) | Peptide which abrogates tnf and/or lps toxicity | |
US20090227750A1 (en) | Mehod for enhancing immune response in mammals | |
US5665346A (en) | Human interleukin-8 analogs | |
JPH03118331A (ja) | 環状フイブリノーゲンレセプター拮抗薬 | |
JPH05506850A (ja) | 好中球刺激ペプチド | |
HRP20030215A2 (en) | Chemokine mutants in the tratment of multiple sclerosis | |
US5587457A (en) | Neutrophil stimulating peptides | |
EP1866334B1 (en) | Inhibitor of endogenous human interferon - gamma | |
US6375928B1 (en) | Neutrophil stimulating peptides | |
Malkowski et al. | The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence | |
Rathjen et al. | Differential effects of small tumour necrosis factor-alpha peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activity. | |
Chirinos-Rojas et al. | Use of a solid-phase random peptide library to identify inhibitors of TNF-α mediated cytotoxicity in vitro | |
JP3059283B2 (ja) | 抗炎症剤 | |
Hugli et al. | The active site of human C4a anaphylatoxin | |
CA2348308A1 (en) | Rantes-derived peptides with anti-hiv activity | |
Suzuki et al. | Localization of chemotactic activity and 64 kD protein phosphorylation for human polymorphonuclear leukocytes in N-terminus of the chemotactic protein LUCTIL-8 | |
AU676842B2 (en) | Neutrophil stimulating peptides | |
JP2005504516A (ja) | HAb18G/CD147における拮抗剤及びその応用 | |
WO1991008754A1 (en) | Medicinal application of m-csf | |
JP2793216B2 (ja) | 粘膜による吸収を高める、ソルビン及び誘導ペプチド | |
WO1993006128A1 (en) | Tnf antagonist peptides | |
US5486595A (en) | Tumor necrosis factor inhibitors | |
JP2004534736A (ja) | 抗血管形成ペプチド |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071019 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081019 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091019 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091019 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101019 Year of fee payment: 9 |
|
LAPS | Cancellation because of no payment of annual fees |